Hypoxia-Inducible Factors: Mediators of Cancer Progression; Prognostic and Therapeutic Targets in Soft Tissue Sarcomas
Soft-tissue sarcomas remain aggressive tumors that result in death in greater than a third of patients due to either loco-regional recurrence or distant metastasis. Surgical resection remains the main choice of treatment for soft tissue sarcomas with pre- and/or post-operational radiation and neoadj...
Main Authors: | Paul J. Zhang, Navid Sadri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/5/2/320 |
Similar Items
-
Integrated Analysis of TME and Hypoxia Identifies a Classifier to Predict Prognosis and Therapeutic Biomarkers in Soft Tissue Sarcomas
by: Ruiling Xu, et al.
Published: (2022-11-01) -
Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship
by: A. Katharina Ceranski, et al.
Published: (2023-03-01) -
Hypoxia signaling in cancer: Implications for therapeutic interventions
by: Yan Zhuang, et al.
Published: (2023-02-01) -
Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
by: Helena Doktorova, et al.
Published: (2015-06-01) -
Soft tissue sarcomas: Evaluation by immunohistochemistry
by: Ibtisam Hussein Al Obaidi
Published: (2020-06-01)